close
This ad will auto close in 10 seconds
Major price cut in cancer, diabetic drugs: Regulator

Major price cut in cancer, diabetic drugs: Regulator

The prices of other important cancer drugs, such as Nanoxel (Rs 1,035) and Frastim (Rs 1,273) have been slashed by 55 per cent and 51 per cent respectively.

'Govt must scale up production of active ingredients of drugs'

'Govt must scale up production of active ingredients of drugs'

The Centre should scale up the production of active ingredients used in drugs to meet the country's need, a government institute has said after it found that over 95 percent of the samples examined during a survey were sourced from China.

Donald Trump's push for lower drug prices to benefit Indian pharma

Donald Trump's push for lower drug prices to benefit Indian pharma

Indian pharmaceutical sector is likely to gain, rather than being impacted, as the new US President Donald Trump aims to reduce drug prices since the country's generic medicines are already affordable, according to industry players.

'Withdrawing customs duty may lead to hike in medicine prices'

'Withdrawing customs duty may lead to hike in medicine prices'

The government's move to withdraw customs duty exemption on imports of around 74 drugs would help in local production of bulk drugs and thereby create demand for the local production but it may also lead to rise in prices for these medicines.

Turing CEO Martin Shkreli arrested in securities fraud probe

Martin Shkreli, a lightning rod for growing outrage over soaring prescription drug prices, was arrested in New York by the FBI on Thursday on securities fraud charges involving his former hedge fund and a pharmaceutical company he previously headed.

Supreme Court court seeks review of drug pricing policy

The Supreme Court has asked the central government to reexamine its pricing policy for essential medicines after a group of non-governmental organisations challenged the provisions, a lawyer involved in the case said.

China lifts price controls on most medicines

In a major reform in its mostly state-controlled health sector, China Tuesday announced that it will lift price controls on most medicines from next month in a bid to keep drug prices in check by adopting market-driven pricing system.

615 drugs under control regime, more steps in offing: Govt

Government said that by next month, it will come out with a new list of life-saving drugs whose prices would be controlled.

Cipla gains after April-June margins expand sequentially

Shares in drugmaker Cipla gain after April-June operating margins beat some estimates.

CII seeks PM's intervention over drug price fixing

Industry chamber CII has sought Prime Minister Narendra Modi's intervention over "unilateral fixing" of drug prices by NPPA saying the exercise based on "an inequitable formula" has done collateral damage to indigenous industry.

Make essential drugs affordable for all: Cipla

Amid US firms' allegations of patent norm violations against Indian pharma companies, leading domestic drug maker Cipla has said that "essential" medicines be made available to people at affordable rates and should not be sold under "monopoly".

Drugs pricing row: HC extends relief to Cipla Ltd till Aug 27

Delhi High Court on Tuesday extended the operation of its earlier order asking the Centre not to take coercive steps against pharma major Cipla Ltd which was told to replace stocks in the market with those carrying reduced prices within 45 days of new price notification.

Regulating drug prices: GoM to meet stakeholders today

A ministerial panel, which is examining the issue of regulating prices of 348 drugs, is likely to meet Monday with stakeholders, including companies and civil society, before finalising the new pharma policy.

Regulating drug prices: GoM to meet stakeholders Monday

A ministerial panel, which is examining the issue of regulating prices of 348 drugs, is likely to meet Monday with stakeholders, including companies and civil society, before finalising the new pharma policy.